Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) caused by niraparib: a novel antineoplastic agent
This is the first reported case of DRESS by hypersensitivity due to niraparib. This case highlights the importance of recognizing DRESS as a potential adverse reaction to niraparib and the efficacy of early corticosteroid intervention. Further research is needed to understand and mitigate the risk.
Authors
- Patricia Rojas Pérez‐Ezquerra
- Cristina Cuevas-Bravo
- Blanca Noguerado-Mellado (ORCID: https://orcid.org/0000-0002-2301-3117)
- Alba Juárez-Guerrero
- Irene Vázquez-Barrera
Institutions
- Hospital General Universitario Gregorio Marañón (ES)
Publication Details
- Journal
- Allergy Asthma and Clinical Immunology
- Published
- 2025-10-02
- DOI
- https://doi.org/10.1186/s13223-025-00959-2
- Citations
- 1
- Primary Topic
- Drug-Induced Adverse Reactions
- Type
- article
- Field-Weighted Citation Impact
- 1.39